Zimmer Biomet completed its acquisition of Monogram Technologies Inc. on 2026-01-01, according to the Form 8-K Monogram Technologies Inc. filed with the SEC on 2025-10-07. The filing's Item 2.01 states no aggregate dollar price. Monogram Technologies Inc. filed the report because the deal made it part of Zimmer Biomet.
| Acquirer | Zimmer Biomet |
|---|---|
| Acquired | Monogram Technologies Inc. |
| Completed | 2026-01-01 |
| Reported by | Monogram Technologies Inc. (MGRM), the company acquired |
| Filing | Form 8-K, filed 2025-10-07 |
Want the whole picture on Zimmer Biomet?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Zimmer Biomet: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Zimmer Biomet covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What the filing says
Merger Agreement On the Closing Date, pursuant to and in accordance with the Merger Agreement, Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly-owned subsidiary of Zimmer Biomet.
More from the filing
At the effective time of the Merger (the " Effective Time "), each outstanding share of the Company's common stock, par value $0.001 per share (" Company common stock "), and each outstanding share of the Company's Series E Redeemable Perpetual Preferred Stock, par value $0.001 per share (the " Series E Preferred Stock "), other than (1) shares owned by the Company, Zimmer Biomet, Merger Sub or any of their respective subsidiaries (" Excluded Shares "), which shares were canceled, and (2) shares with respect to which appraisal rights were properly exercised and not withdrawn under Delaware law
On October 7, 2025, Zimmer Biomet and Computershare Trust Company, N.A. entered into the Contingent Value Rights Agreement substantially in the form attached as Exhibit B to the Merger Agreement (the " CVR Agreement "), governing the terms of the CVRs to be received by the Company's stockholders and optionholders.
The CVRs are not transferable except under certain limited circumstances, are not evidenced by a certificate or other instrument and are not registered or listed for trading.
Quoted from Monogram Technologies Inc.'s Form 8-K.
This is the only completed acquisition Zimmer Biomet reported under Item 2.01 in the last twelve months, as far as the filings of the companies it bought show.
Who runs it now, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on Zimmer BiometLook up Zimmer Biomet and see what is on record before you decide.
Get the free SnapshotWhere this comes from
A public company must file a current report on Form 8-K with the SEC within four business days of completing a significant acquisition or disposition of assets, under Item 2.01 of the report. The acquired company sometimes files one too, when the deal makes it a subsidiary of the buyer.
Every fact on this page is taken from one of those filings and linked to it: which company acquired which, the date the filing gives for completion, and the price when the filing states one in dollars, shown next to the sentence that states it. A filing states what was bought and on what terms; it rarely states why, and neither does this page.